Mood Disorders: Depressions Flashcards
(152 cards)
What are the different depressive disorders included in the DSM-5?
The depressive disorders in the DSM-5 include disruptive mood dysregulation disorder, major depressive disorder, persistent depressive disorder (dysthymia), premenstrual dysphoric disorder, substance/medication-induced depressive disorder, depressive disorder due to another medical condition, other specified depressive disorder, and unspecified depressive disorder.
What is the clinical definition of depression according to the DSM-5?
A major depressive episode requires the presence of five (or more) specific symptoms during the same 2-week period, including depressed mood or loss of interest/pleasure, along with other symptoms such as changes in weight or appetite, sleep disturbances, psychomotor changes, fatigue, feelings of worthlessness or guilt, difficulty concentrating, and thoughts of death or suicide.
What are the key features of major depressive disorder?
Major depressive disorder involves discrete episodes lasting at least 2 weeks, with clear changes in affect, cognition, and vegetative functions. It can be recurrent and is distinguished from normal sadness or grief.
What are the core criteria for diagnosing Major Depressive Disorder (MDD) in the DSM-5?
To meet the criteria for MDD, an individual must experience:
Depressed Mood: A persistent feeling of sadness or emptiness.
Loss of Interest or Pleasure: Markedly diminished interest or pleasure in almost all activities that were once enjoyable.
What are the diagnostic features of major depressive disorder?
The diagnostic features of major depressive disorder include the presence of symptoms nearly every day, with exceptions for weight change and suicidal ideation. Depressed mood must be predominant, and clinicians should be attentive to symptoms such as insomnia, fatigue, and somatic complaints.
In addition to the two core criteria, the individual must also experience a minimum of five of what symptoms (as outlined in the DSM-5) during the same two-week period?
Significant Weight Changes: A significant loss of weight (without dieting) or weight gain, or a decrease or increase in appetite.
Sleep Disturbances: Insomnia (inability to sleep) or hypersomnia (excessive sleep) nearly every day.
Psychomotor Changes: Observable agitation (restlessness) or psychomotor retardation (slowed movements and speech) nearly every day.
Fatigue: Persistent fatigue or loss of energy.
Feelings of Worthlessness or Guilt: Feelings of worthlessness or excessive or inappropriate guilt, which may be delusional.
Difficulty Concentrating: Diminished ability to think or concentrate, or indecisiveness, nearly every day.
Recurrent Thoughts of Death: Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan to commit suicide.
What is the significance of the symptoms during a major depressive episode?
The symptoms represent a change from the individual’s previous functioning and must be present nearly every day for a duration of at least 2 weeks to meet the criteria for a major depressive episode.
How does the DSM-5 approach the diagnosis of depression, considering the neurobiology of depression and the heterogeneity among patients?
The DSM-5 categorizes depression under “Major Depressive Disorder,” taking into account symptoms such as persistent sadness, lack of interest in activities, and changes in sleep or appetite. It acknowledges the variability in depression’s manifestation by requiring a specific number of symptoms for a diagnosis, allowing for individual differences in symptomatology.
This aligns with the understanding that depression, or “the depressions,” encompasses a wide range of experiences and symptoms, influenced by both genetic and environmental factors.
Evaluation Challenges with Medical Conditions
Symptoms overlap with general medical conditions, necessitating careful assessment.
Non-vegetative symptoms of dysphoria, anhedonia, guilt, impaired concentration, or suicidal thoughts should be assessed meticulously.
Modified criteria focusing only on non-vegetative symptoms yield similar diagnostic outcomes as full criteria.
Mood and depression
Depression is considered to be a disorder of mood.
The low mood may fluctuate during the day - it may be worse in the morning and relatively better in the afternoon. This is called ‘diurnal variation’, which often accompanies a more severe type of depression.
What is the significance of recognizing depression as a “pathway illness” in the treatment of depression?
Recognizing depression as a “pathway illness” underscores the importance of personalized treatment.
Given the complex interplay of genetic risks and environmental stressors in depression, it is unlikely that a one-size-fits-all approach to treatment would be effective.
This perspective encourages the development and application of tailored interventions, whether pharmacological or psychological, to meet the unique needs of each individual, aligning with the DSM-5’s nuanced approach to diagnosing and treating mental disorders.
How does the issue of stigma, including “pill shaming,” relate to the treatment of depression and the DSM-5’s role in patient care?
The DSM-5’s recognition of depression as a medical condition helps combat stigma by providing a formal diagnostic framework that legitimizes the experiences of those suffering.
However, stigma and “pill shaming” persist, sometimes deterring individuals from seeking or continuing treatment, including antidepressants. Addressing these issues in patient care involves not only adhering to DSM-5 diagnostic criteria but also fostering an environment of understanding and support for all treatment modalities, highlighting the importance of de-stigmatizing mental health treatment and promoting a holistic approach to care.
How can the diversity of patients’ backgrounds and genetic makeups impact the effectiveness of depression treatments according to the DSM-5 framework?
The DSM-5’s framework for diagnosing depression allows for the consideration of individual differences, including diverse backgrounds and genetic makeups, in treatment planning.
This approach acknowledges that the effectiveness of treatments, such as antidepressants or psychological therapies, can vary widely among individuals. Tailoring treatment to the individual—taking into account their unique genetic predispositions, life stressors, and resilience factors—is crucial for effective care, reflecting the DSM-5’s emphasis on personalized medicine in the field of psychiatry.
What are the primary diagnostic tools used for identifying depression, and how do their criteria for diagnosis differ?
The primary diagnostic tools for identifying depression are the ICD-10 (International Classification of Diseases, 10th Revision) and the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition).
Both systems have specific criteria for diagnosing depression, but they differ in the exact number and types of symptoms required for a diagnosis.
The DSM-5, for example, outlines criteria including changes in mood, interest, and cognition, but a diagnosis does not necessitate the presence of all listed symptoms, allowing for variability among individuals.
How does the DSM-5 address changes in mood, interest, and cognition in diagnosing depression?
The DSM-5 addresses depression by identifying key symptoms that include noticeable changes in mood (such as persistent sadness), interest (loss of interest in previously enjoyed activities), and cognition (difficulty thinking, concentrating, or making decisions).
For a diagnosis, individuals must exhibit a certain number of these symptoms, which reflect significant changes from their previous functioning, over a specific period.
What criticisms are leveled against the DSM-5 and similar diagnostic systems regarding their approach to diagnosing depression?
Criticisms of the DSM-5 and similar diagnostic systems include accusations of cultural bias, suggesting they may be Western-centric and prioritize internal, individual factors over external, environmental influences.
Critics argue that these systems may overlook the role of external factors, such as relationship problems or life stressors, by focusing on symptoms present within the individual, thereby implying depression is a unitary condition rather than a complex, multifaceted disorder.
Despite criticisms, what is the utility of diagnostic systems like the DSM-5 in understanding and treating depression?
Despite their criticisms, diagnostic systems like the DSM-5 have significant utility in the understanding and treatment of depression.
They provide a standardized framework for identifying and classifying mental health conditions, facilitating communication among professionals, guiding research, and informing treatment approaches.
While acknowledging their limitations, these systems are crucial for ensuring consistent and effective care, emphasizing the need for ongoing evaluation and adaptation to encompass the diverse experiences of individuals with depression.
How do the DSM-5 and other diagnostic manuals address the criticism that they view depression as a “unitary thing”?
Although the DSM-5 and other diagnostic manuals have been criticized for treating depression as a “unitary thing,” they also offer diagnostic criteria that allow for variability in symptom expression and acknowledge the presence of multiple subtypes and specifiers.
This approach attempts to capture the heterogeneity of depression, recognizing differences in severity, duration, and presence of specific features like psychotic symptoms or seasonal patterns. The acknowledgment of these variations within the diagnostic criteria aims to address the complexity of depression and the unique experiences of those affected.
What is one hypothesis regarding the prevalence of depression in modern society?
One hypothesis suggests that modern lifestyles, characterized by chronic stress, poor diet (high in sugar and fat), and increased prevalence of cardiovascular diseases and diabetes, contribute to the prevalence of depression.
This perspective argues that the human brain, evolved to manage acute stressors, is ill-equipped for the chronic stresses of modern life, such as examinations, job interviews, and educational pressures, leading to potential damage to our brain and, subsequently, depression.
How does the social evolution theory explain the existence of depression?
The social evolution theory proposes that depression evolved as a mechanism to avoid conflict with more powerful individuals within a social group. By experiencing depression, individuals might reduce the likelihood of confrontations with dominant group members, thereby avoiding direct conflict and potential harm.
This adaptation could have helped maintain social harmony and individual safety in ancestral environments.
What do Raison and Miller suggest about the evolutionary relationship between depression and microbes?
Raison and Miller argue that depression represents an aspect of human evolution intricately linked with microbes and bacteria.
According to them, depression may function as a mechanism to conserve energy during illness, allowing the immune system to effectively fight infections. This theory highlights a complex co-evolution of humans with microbial environments, suggesting that behaviors associated with depression, such as social avoidance and energy conservation, have benefits in terms of infection management.
How is inflammation related to depression, according to current research interest?
There is growing interest in the role of inflammation in depression, with research suggesting a significant association between immune activation/inflammation and the development of depressive symptoms.
This perspective supports the idea that depression may be part of an evolutionary response to illness, where inflammatory processes that are part of the body’s immune response can influence brain function and lead to depressive states, emphasizing the need for further exploration of the immune system’s role in mental health.
What is the median onset age of Major Depressive Disorder (MDD) according to WHO epidemiological data?
The median onset age of Major Depressive Disorder (MDD) is about 25 years of age, and this onset age is consistent across different countries and genders, as reported by the World Health Organization (WHO).
What is the average 12-month prevalence rate of Major Depressive Disorder (MDD) as per WHO data?
According to the World Health Organization (WHO), the average 12-month prevalence rate of Major Depressive Disorder (MDD) is six percent among adults.